Skip to main content
. 2022 Oct 28;18(10):e1010926. doi: 10.1371/journal.ppat.1010926

Table 1. PfCRT haplotypes and PPQ and CQ phenotypes of lines used herein.

PfCRT Haplotypes pm2/3 pfmdr1 Phenotype
Parasite Line 74 75 76 97 145 220 271 326 343 353 356 371 Copies Copies PPQ CQ
Dd2 I E T H F S E S M G T I 1 2 S R
Dd2Dd2crt I E T H F S E S M G T I 1 2 S R
Dd2F145Icrt I E T H I S E S M G T I 1 2 Rhigh S
Dd2M343Lcrt I E T H F S E S L G T I 1 2 Rlow S
Dd2G353Vcrt I E T H F S E S M V T I 1 2 Rmod S
Dd23D7crt M N K H F A Q N M G I R 1 2 S S
RF7 I E T H F S E S L G T I 3 1 Rhigh R
RF12 I E T Y F S E S M G T I 2 1 Rhigh R

All parasite lines were cloned prior to use (Dd2-B2 was used for Dd2). RF7 and RF12 carry the K13 C580Y mutation that confers in vitro resistance to artemisinin derivatives. CQ, chloroquine; mod, moderate; pm2/3, plasmepsins 2 and 3; pfmdr1, P. falciparum multidrug resistance protein 1; PPQ, piperaquine.